The Food and Drug Administration has rejected some products because of concerns about youth users.

We all understand the dangers of smoking—but the debate over vapes, nicotine pouches and other tobacco alternatives rages on: Can vaping really save lives? Or are nicotine alternatives a slippery slope: a dangerous gateway to lifelong substance use? Professors Jasjit Ahluwalia and Jennifer Tidey discuss their takes on a harm reduction and how it applies to the modern nicotine landscape.

The debate over vapes, nicotine pouches and the quest to reduce the global scourge of tobacco-related diseases and fatalities.